Borderline Personality Disorder (BPD): Symptoms, Relationships & Treatment

Borderline personality disorder (BPD) is a mental health condition characterised by pervasive instability across three interconnected domains: emotional experience, sense of self, and interpersonal relationships. It is classified as a Cluster B personality disorder in the DSM-5-TR, alongside antisocial, narcissistic, and histrionic personality disorders, all of which share patterns of dramatic, emotionally intense, or erratic behaviour.

The word "borderline" is a historical artefact, originally used to describe people thought to sit on the border between neurosis and psychosis. It is no longer clinically meaningful as a descriptor and is increasingly recognised as stigmatising. What the condition actually involves is a profound difficulty with emotional regulation, a fragile and unstable sense of self, and relationships that become intensely entangled with the person's fear of being abandoned.

BPD affects an estimated 0.7% to 2.7% of the general adult population, making it more common than most people realise. Its prevalence is considerably higher in clinical settings: approximately 6% in primary care, 11 to 12% in outpatient psychiatric services, and 22% in inpatient psychiatric settings. This concentration in clinical populations reflects both the severity of impairment associated with BPD and the frequency with which people with BPD seek help during crises.

While women are slightly more likely to be diagnosed in community samples, the gender difference is more pronounced in clinical settings, partly because the presentation of BPD differs by gender. Men with BPD are more likely to show intense anger and impulsivity, while women more commonly experience chronic emptiness, affective instability, and self-harm. BPD is significantly underdiagnosed in men as a result.

BPD is a treatable condition with well-evidenced psychological interventions, and longitudinal research shows that symptoms remit meaningfully over time for many people with the disorder.

People with BPD often describe their emotional experience as living without skin. Everything hits harder and lasts longer than it seems to for other people. An ordinary interaction can feel intensely affirming or catastrophically rejecting, and the shift between those states can happen in minutes rather than hours or days.

One of the most defining and least discussed features of BPD is the experience of emotional pain in response to perceived rejection or abandonment. This is not the ordinary discomfort of disappointment. It is an acute, total experience of distress that can feel impossible to contain and that drives the impulsive behaviours and relationship ruptures most often associated with the condition. The fear of being left, whether it is realistic or not, activates the same alarm system that real abandonment would, with the same urgency and intensity.

Living with an unstable sense of self means that the answer to "who am I" genuinely shifts across contexts and relationships. Values, goals, preferences, and even fundamental beliefs about what kind of person one is can feel radically different depending on who the person is with and what is happening. It is a genuine absence of the stable self-concept that most people take for granted.

Periods of intense emotional flooding can alternate with a quality of inner emptiness that is equally difficult to bear. When emotions settle, what remains is a flat, hollow feeling that the person may go to great lengths to fill, through intensity, risk-taking, closeness, or substance use.

To people close to someone with BPD, the experience is often one of intensity and confusion. The relationship can feel uniquely deep and significant in its good periods, and suddenly, without apparent reason, it can shift into hostility or despair. The person may idealise those close to them with a completeness that feels overwhelming, and devalue them with equal completeness, sometimes within the same day.

This oscillation between idealisation and devaluation, known clinically as splitting, is not manipulation. It is a genuine cognitive and emotional pattern in which the person's experience of others collapses into all-good or all-bad, with little capacity for the stable middle ground that healthy relationships require. For the people on the receiving end, it can feel like being the most important person in someone's world one day and a stranger or enemy the next.

Partners and family members often describe walking on eggshells, monitoring what they say and do to avoid triggering a crisis, adjusting their behaviour around the other person's emotional state, and feeling simultaneously indispensable and blamed. These relational dynamics are distressing for both people involved and require specific support, not simply instruction to set better limits.

The stigma attached to BPD is real and widespread, including within clinical settings. People with BPD are sometimes described as manipulative, attention-seeking, or difficult. These characterisations are clinically inaccurate and deeply harmful. Most of the behaviours that attract those labels, including self-harm, repeated crises, or emotionally intense communications, are expressions of genuine distress in a person who has not yet developed the skills to manage that distress in less harmful ways.

The DSM-5 requires five or more of the following nine criteria, representing a pervasive pattern across contexts and time, with onset in early adulthood.

• Frantic efforts to avoid real or imagined abandonment. This may include intense attempts to prevent someone from leaving, sudden emotional escalation when separation feels imminent, or pre-emptive ending of relationships before abandonment can occur.
• A pattern of unstable and intense interpersonal relationships, characterised by alternating between extremes of idealisation and devaluation.
• Identity disturbance: a markedly and persistently unstable sense of self or self-image, including uncertainty about values, goals, sexual identity, or career direction.
• Impulsivity in at least two areas that are self-damaging, such as reckless spending, substance use, unsafe sex, binge eating, or reckless driving.
• Recurrent suicidal behaviour, gestures, or threats, or self-mutilating behaviour. Between 50% and 80% of people with BPD engage in self-harm at some point. Research estimates that up to 10% of people with BPD die by suicide.
• Affective instability due to marked reactivity of mood, including intense episodes of sadness, irritability, or anxiety lasting hours to a few days.
• Chronic feelings of emptiness.
• Inappropriate, intense anger or difficulty controlling anger, including frequent loss of temper, sarcasm, or recurrent physical fights.
• Transient, stress-related paranoid ideation or severe dissociative symptoms.

A key clinical feature is that all nine criteria vary considerably in presentation, and many people with BPD function well in some areas of life while struggling intensely in others. BPD is one of the most heterogeneous conditions in the DSM: two people with the disorder may share only one or two symptoms in common and still carry the same diagnosis.

BPD does not have a single cause. Research consistently identifies an interaction between genetic vulnerability, neurobiological factors, and early adverse experience as the most supported model of its development.

Genetics and heritability. Twin and family studies estimate the heritability of BPD at approximately 37 to 69%. Having a first-degree relative with BPD increases risk, and multiple candidate genes related to serotonin, dopamine, and stress response systems have been identified as potentially involved. Genetic risk for BPD overlaps meaningfully with risk for depression, PTSD, and other mood and personality disorders.

Adverse childhood experiences. There is strong and consistent evidence linking childhood trauma, abuse, and neglect to the development of BPD. Rates of childhood sexual abuse, physical abuse, emotional abuse, and neglect are significantly elevated in people with BPD compared to the general population and to people with other psychiatric diagnoses. Importantly, not everyone with BPD has a history of abuse, and not everyone who experiences abuse develops BPD. Adverse childhood experiences interact with genetic and neurobiological vulnerability to produce the disorder, rather than causing it directly in all cases.

Neurobiological factors. Neuroimaging research has identified differences in the amygdala, hippocampus, and prefrontal cortex in people with BPD. The amygdala, which processes threat and emotional intensity, shows altered activity patterns, contributing to the heightened emotional reactivity characteristic of the disorder. The ventromedial and orbitofrontal prefrontal cortex, which normally regulates emotional response and facilitates the consideration of consequences, shows reduced regulatory influence. The HPA axis, governing the stress hormone system, also shows patterns consistent with chronic stress-related changes. Serotonergic and dopaminergic systems are both implicated. The neurobiological picture is complex and research continues, but the emerging consensus points to a brain that is highly sensitive to emotional and social stimuli, with reduced top-down regulation of those responses.

Invalidating environments. Developmental theorist Marsha Linehan, who developed the primary evidence-based treatment for BPD, proposed that the disorder often emerges from the interaction between biological emotional sensitivity and an invalidating early environment, one in which the child's emotional experiences were consistently dismissed, denied, or punished. In such environments, a child never learns to trust their own emotional signals or to regulate them through the natural scaffolding of attuned caregiving.

What they share. Both conditions involve significant emotional intensity, impulsive behaviour, relational difficulties, and elevated risk of self-harm and suicide. Both can be episodic in nature, and both carry stigma that delays diagnosis and treatment-seeking. This surface similarity is why misdiagnosis is so common, and why careful assessment over time is essential.

The core difference lies in the source and duration of mood changes.

In bipolar disorder, mood changes organise into sustained episodes of depression, mania, or hypomania that typically last days to weeks and affect sleep, energy, activity level, and cognition. These episodes are largely internal in origin and tend to follow a cycle that does not necessarily correspond to external events, particularly in bipolar I.

In BPD, emotional shifts are typically reactive rather than episodic. They are triggered by interpersonal events, particularly perceived rejection, criticism, or abandonment, and they tend to resolve more quickly, often within hours rather than days. The emotional dysregulation in BPD is tied specifically to relationships and the sense of self, rather than to the cycling energy and mood states that characterise bipolar disorder.

A practical distinction. If the emotional shift was triggered by something in a relationship or by a perceived slight, and it resolved in hours, BPD is the more likely explanation. If the mood change arrived gradually without a specific trigger, affects energy and sleep over days to weeks, and includes a period of elevated energy or decreased need for sleep, bipolar disorder is the more likely explanation.

BPD and bipolar do co-occur. Research estimates that approximately 10% of people with bipolar I and 16 to 20% of people with bipolar II also meet criteria for BPD. When both are present, treatment must address both, combining pharmacotherapy for bipolar disorder with psychotherapy specifically designed for BPD.

BPD and bipolar disorder are among the most frequently confused mental health diagnoses, and the confusion has real consequences for treatment. Getting the diagnosis right matters because the primary treatments for the two conditions are different. What they share. Both conditions involve significant emotional intensity, impulsive behaviour, relational difficulties, and elevated risk of self-harm and suicide. Both can be episodic in nature, and both carry stigma that delays diagnosis and treatment-seeking. This surface similarity is why misdiagnosis is so common, and why careful assessment over time is essential. The core difference lies in the source and duration of mood changes. In bipolar disorder, mood changes organise into sustained episodes of depression, mania, or hypomania that typically last days to weeks and affect sleep, energy, activity level, and cognition. These episodes are largely internal in origin and tend to follow a cycle that does not necessarily correspond to external events, particularly in bipolar I. In BPD, emotional shifts are typically reactive rather than episodic. They are triggered by interpersonal events, particularly perceived rejection, criticism, or abandonment, and they tend to resolve more quickly, often within hours rather than days. The emotional dysregulation in BPD is tied specifically to relationships and the sense of self, rather than to the cycling energy and mood states that characterise bipolar disorder. A practical distinction. If the emotional shift was triggered by something in a relationship or by a perceived slight, and it resolved in hours, BPD is the more likely explanation. If the mood change arrived gradually without a specific trigger, affects energy and sleep over days to weeks, and includes a period of elevated energy or decreased need for sleep, bipolar disorder is the more likely explanation. BPD and bipolar do co-occur. Research estimates that approximately 10% of people with bipolar I and 16 to 20% of people with bipolar II also meet criteria for BPD. When both are present, treatment must address both, combining pharmacotherapy for bipolar disorder with psychotherapy specifically designed for BPD.

BPD is one of the most comorbid psychiatric conditions. Research indicates that the vast majority of people with BPD meet criteria for at least one other diagnosis, and multiple comorbidities are common.

Depression. Major depressive disorder co-occurs with BPD at very high rates, estimated at 60 to 80% over the lifetime. Depression in the context of BPD is often characterised by intense emotional pain, feelings of worthlessness, and self-destructive impulses, and may be harder to treat when BPD is not also being addressed. Standard antidepressants have limited evidence for the core symptoms of BPD, though they may address comorbid depression.

PTSD and complex PTSD. Given the high rates of childhood trauma in the histories of people with BPD, PTSD and particularly complex PTSD are common comorbidities. BPD and CPTSD overlap significantly in clinical presentation and are sometimes difficult to distinguish, with some researchers arguing they exist on a trauma-related spectrum. Correct identification matters because treatment of trauma may be a necessary component of BPD treatment rather than a separate undertaking.

Substance use disorders. Elevated rates of substance use disorders co-occur with BPD, likely driven by the use of alcohol and other substances to manage emotional pain and emptiness. Substance use can significantly worsen BPD symptoms, particularly impulsivity and relationship instability, and requires integrated treatment.

Anxiety disorders. Generalised anxiety, panic disorder, and social anxiety are highly prevalent in BPD, often as secondary developments from the chronic interpersonal and emotional stress the disorder generates.

Eating disorders. BPD co-occurs with bulimia nervosa at significantly elevated rates. The impulsivity, emotional dysregulation, and chronic emptiness of BPD interact with the compensatory behaviours of bulimia, making eating disorders particularly difficult to treat in this context.

ADHD. ADHD and BPD share features including impulsivity and emotional dysregulation, and they co-occur at elevated rates. The combination can complicate diagnosis and requires careful differentiation, as the impulsivity of ADHD is neurobiological in nature while the impulsivity of BPD is predominantly driven by emotional dysregulation in interpersonal contexts.

The people I work with who have BPD are not difficult. They are people in enormous pain who have never been given the tools to manage emotions that are genuinely more intense than what most people experience. When the stigma drops, and they start to understand that what they have is a treatable condition, something shifts. DBT gives people skills they never had. And what I see over and over again is that people who seemed unmanageable become people who can hold jobs, sustain relationships, and build lives that feel worth living. The prognosis for BPD with good treatment is actually better than most people believe."

— Kanani Baker

BPD is significantly undertreated, partly because of the stigma attached to the diagnosis and partly because the disorder's relational intensity can make it difficult for people to sustain the therapeutic relationships treatment requires. Despite this, BPD responds well to specific, evidence-based psychotherapies, and longitudinal research shows substantial improvement over time for many people who receive appropriate treatment.

Consider reaching out to a professional if you are noticing:

• A persistent pattern of relationships that alternate between intense closeness and rupture
• Intense fear of being abandoned, even in stable relationships, that drives behaviour you later regret
• A sense that you do not know who you are, or that your identity shifts significantly across relationships or contexts
• Rapid, reactive emotional shifts that feel triggered by interpersonal events and that are difficult to contain
• Chronic feelings of emptiness or meaninglessness
• Impulsive behaviours, including self-harm, that you use to manage emotional pain
• Suicidal thoughts or urges, particularly in the context of relational crises

Evidence-based treatments for BPD include:

• Mentalization-Based Treatment (MBT) is a psychodynamic approach developed specifically for BPD that focuses on building the capacity to understand one's own and others' mental states, including motivations, feelings, and intentions. Impairment in mentalizing, the ability to think about behaviour in terms of underlying mental states, is a central feature of BPD identified in recent research, and MBT directly targets this deficit. MBT has strong randomised controlled trial evidence and is particularly appropriate for people whose BPD has roots in early attachment disruption.
• Transference-Focused Psychotherapy (TFP) is a psychodynamically grounded treatment that uses the therapeutic relationship as the primary site of intervention, working with how the person with BPD relates to the therapist as a window into the relational patterns that drive the disorder. TFP has demonstrated effectiveness in multiple clinical trials.
• Medication. There are currently no medications with consistent evidence for the core features of BPD. However, medications may be used to address specific comorbid symptoms such as depression, anxiety, or severe impulsivity, always under close clinical supervision and not as a replacement for psychotherapy.

For people with both BPD and bipolar disorder, treatment requires addressing both conditions simultaneously, typically through DBT-based therapy for BPD symptoms combined with mood-stabilising medication for the bipolar component.